| ManRos Therapeutics | |
| Keywords : ManRos, Therapeutics |
| Last Update : | 27/December/2011 |
| Google PR : | 4 |
| Archive : | Check how did the site look in the past? |
WWW.manros-therapeutics .com - website information, analysis and reviews
General Info Hosting Info Alexa Ranking Quantcast Ranking Compete Ranking Mywot Ranking Widgets Reviews
General website information 
Server and Hosting Information
| Site IP address : | manros-therapeutics.com |
| Server type : | Apache |
| Powered by : | PHP/5.1.6 |
| DNS 1 : | a.dns.gandi.net |
| DNS 2 : | b.dns.gandi.net |
| DNS 3 : | c.dns.gandi.net |
| MX Domain 1 : | alt1.aspmx.l.google.com |
| MX Domain 2 : | alt2.aspmx.l.google.com |
| MX Domain 3 : | aspmx.l.google.com |
| MX Domain 4 : | aspmx2.googlemail.com |
| MX Domain 5 : | aspmx3.googlemail.com |
| MX Domain 6 : | aspmx4.googlemail.com |
| MX Domain 7 : | aspmx5.googlemail.com |
Alexa Ranking Information - Alexa.com
| Alexa rank : | 25,628,790 |
| Description : | Manros-therapeutics.com has a three-month global Alexa traffic rank of 25,628,790. |
Compare this site to:
Search queries:
| roscoff manros | 29.00% |
| hervè galons | 22.39% |
| hervè galons | 15.37% |
| kinase inhibition and molecular structure | 9.50% |
| eric anderson new y 2d40 ork rockefeller univ | 7.11% |
| arnoud meijer phast | 5.94% |
| techno rc | 3.75% |
| cerep kinase panel | 2.23% |
| esrnb series | 1.81% |
| dk5 butyrolacton | 1.08% |
Quantcast Ranking Information - Quantcast.com
| Quantcast rank : | 0 | Average US daily traffic : | 0 |
Compete Ranking Information - Compete.com
| Compete rank : | 0 |
| Average daily unique visitors : | 0 |
MyWot Ranking Information - MyWot.com
| MyWot rank : | 0 |
| Trustworthiness : | 0 |
| Vendor reliability : | 0 |
| Privacy : | 0 |
| Child safety : | 0 |
Widgets
Stats summary widget
|
|
|
Ratings widget
|
|
|